Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-07-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383522000491 |
| _version_ | 1818521999009382400 |
|---|---|
| author | Bin Tu Huiyuan Wang Xinran An Jingkun Qu Qianqian Li Yanrong Gao Mingjie Shi Hong Qiu Yongzhuo Huang |
| author_facet | Bin Tu Huiyuan Wang Xinran An Jingkun Qu Qianqian Li Yanrong Gao Mingjie Shi Hong Qiu Yongzhuo Huang |
| author_sort | Bin Tu |
| collection | DOAJ |
| first_indexed | 2024-12-11T01:58:52Z |
| format | Article |
| id | doaj.art-c597a957ad6b4df5be9acf2ff7197fa8 |
| institution | Directory Open Access Journal |
| issn | 2211-3835 |
| language | English |
| last_indexed | 2024-12-11T01:58:52Z |
| publishDate | 2022-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Acta Pharmaceutica Sinica B |
| spelling | doaj.art-c597a957ad6b4df5be9acf2ff7197fa82022-12-22T01:24:32ZengElsevierActa Pharmaceutica Sinica B2211-38352022-07-0112731873194Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variantsBin Tu0Huiyuan Wang1Xinran An2Jingkun Qu3Qianqian Li4Yanrong Gao5Mingjie Shi6Hong Qiu7Yongzhuo Huang8State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; Corresponding authors. Tel./fax: +86 21 20231981.State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Michigan College of Pharmacy, Ann Arbor, MI 48109, USAState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, ChinaState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; Nanchang University College of Pharmacy, Nanchang 330006, ChinaState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528437, China; NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Shanghai 201203, China; Taizhou University, School of Advanced Study, Institute of Natural Medicine and Health Product, Taizhou 318000, China; Corresponding authors. Tel./fax: +86 21 20231981.http://www.sciencedirect.com/science/article/pii/S2211383522000491SARS-CoV-2Delta variantHeparan sulfateSpike proteinHeparin nanoparticlePulmonary delivery |
| spellingShingle | Bin Tu Huiyuan Wang Xinran An Jingkun Qu Qianqian Li Yanrong Gao Mingjie Shi Hong Qiu Yongzhuo Huang Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants Acta Pharmaceutica Sinica B SARS-CoV-2 Delta variant Heparan sulfate Spike protein Heparin nanoparticle Pulmonary delivery |
| title | Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants |
| title_full | Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants |
| title_fullStr | Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants |
| title_full_unstemmed | Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants |
| title_short | Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants |
| title_sort | inhaled heparin polysaccharide nanodecoy against sars cov 2 and variants |
| topic | SARS-CoV-2 Delta variant Heparan sulfate Spike protein Heparin nanoparticle Pulmonary delivery |
| url | http://www.sciencedirect.com/science/article/pii/S2211383522000491 |
| work_keys_str_mv | AT bintu inhaledheparinpolysaccharidenanodecoyagainstsarscov2andvariants AT huiyuanwang inhaledheparinpolysaccharidenanodecoyagainstsarscov2andvariants AT xinranan inhaledheparinpolysaccharidenanodecoyagainstsarscov2andvariants AT jingkunqu inhaledheparinpolysaccharidenanodecoyagainstsarscov2andvariants AT qianqianli inhaledheparinpolysaccharidenanodecoyagainstsarscov2andvariants AT yanronggao inhaledheparinpolysaccharidenanodecoyagainstsarscov2andvariants AT mingjieshi inhaledheparinpolysaccharidenanodecoyagainstsarscov2andvariants AT hongqiu inhaledheparinpolysaccharidenanodecoyagainstsarscov2andvariants AT yongzhuohuang inhaledheparinpolysaccharidenanodecoyagainstsarscov2andvariants |